SCHEMBL6565853

SCHEMBL6565853

CC(C)CC(OC(=O)NCc1ccccc1)C(=O)N(Cc1ccccc1)C1(C#N)CCNC1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CTSL P07711 4/20 0.42
CTSS P25774 4/20 0.42
CTSB P07858 3/20 0.42
CTSK P43235 3/20 0.42
ANPEP P15144 1/20 0.37
ALDH1A1 P00352 1/20 0.35
MAPT P10636 3/20 0.35
PSMB1 P20618 1/20 0.35
S1PR4 O95977 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.34
CASP3 P42574 2/20 0.34
POLB P06746 2/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
NPSR1 Q6W5P4 1/20 0.34
GPR55 Q9Y2T6 1/20 0.34
MMP8 P22894 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7435732 0.92 CTSL (0.41) CTSLCTSSCTSBCTSKANPEP
SCHEMBL6565014 0.88 CTSL (0.38) CTSLCTSSCTSBCTSKANPEP
SCHEMBL6565790 0.88 CTSL (0.40) CTSLCTSSCTSBCTSKANPEP
SCHEMBL7434282 0.88 CTSL (0.40) CTSLCTSSCTSBCTSKANPEP
SCHEMBL6565502 0.87 CTSL (0.40) CTSLCTSSCTSBCTSKANPEP
SCHEMBL7426242 0.87 CTSL (0.41) CTSLCTSSCTSBCTSKANPEP
SCHEMBL6567023 0.86 CTSL (0.42) CTSLCTSSCTSBCTSKANPEP
SCHEMBL3903810 0.85 CTSS (0.43) CTSLCTSSCTSBCTSKANPEP
SCHEMBL7434484 0.85 CTSL (0.38) CTSLCTSSCTSBCTSKANPEP
SCHEMBL6565027 0.85 CTSL (0.37) CTSLCTSSCTSBCTSKALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002100849-A2 NOVEL NITRILES USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2002-12-19 WO claimed
WO-2002100849-A2 NOVEL NITRILES USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2002-12-19 WO disclosed